全文获取类型
收费全文 | 994篇 |
免费 | 48篇 |
国内免费 | 66篇 |
专业分类
电工技术 | 6篇 |
综合类 | 21篇 |
化学工业 | 574篇 |
金属工艺 | 48篇 |
机械仪表 | 68篇 |
建筑科学 | 54篇 |
轻工业 | 78篇 |
无线电 | 80篇 |
一般工业技术 | 50篇 |
冶金工业 | 27篇 |
原子能技术 | 50篇 |
自动化技术 | 52篇 |
出版年
2024年 | 1篇 |
2023年 | 33篇 |
2022年 | 202篇 |
2021年 | 194篇 |
2020年 | 43篇 |
2019年 | 25篇 |
2018年 | 18篇 |
2017年 | 24篇 |
2016年 | 35篇 |
2015年 | 52篇 |
2014年 | 61篇 |
2013年 | 61篇 |
2012年 | 44篇 |
2011年 | 75篇 |
2010年 | 33篇 |
2009年 | 26篇 |
2008年 | 29篇 |
2007年 | 24篇 |
2006年 | 16篇 |
2005年 | 29篇 |
2004年 | 16篇 |
2003年 | 9篇 |
2002年 | 16篇 |
2001年 | 5篇 |
2000年 | 7篇 |
1999年 | 7篇 |
1998年 | 5篇 |
1997年 | 3篇 |
1996年 | 4篇 |
1995年 | 2篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 1篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1987年 | 1篇 |
排序方式: 共有1108条查询结果,搜索用时 15 毫秒
51.
Aprahamian M Bour G Akladios CY Fylaktakidou K Greferath R Soler L Marescaux J Egly JM Lehn JM Nicolau C 《Chembiochem : a European journal of chemical biology》2011,12(5):777-783
Myo-inositol trispyrophosphate (ITPP), a synthetic allosteric effector of hemoglobin, increases the regulated oxygen-releasing capacity of red blood cells (RBCs), leading to suppression of hypoxia-inducible factor 1α (HIF-1α) and to down-regulation of hypoxia-inducible genes such as vascular endothelial growth factor (VEGF). As a consequence, tumor growth is markedly affected. The effect of weekly intravenous injection of ITPP on an orthotopic, syngenic rat hepatocellular carcinoma (HCC) model was compared to that for untreated animals and animals subjected to conventional Doxorubicin chemotherapy. The longitudinal examination of HCC was performed by microCT imaging, and the cellular and molecular changes were evaluated by histology and Western blotting analysis of HIF-1α, VEGF, and caspase-3 gene expression in the tumor and in the surrounding liver. Hematologic impact was evaluated by blood cell-count measurement and determination of P50 (oxygen partial pressure for a 50 % oxygen saturation of hemoglobin). The HCC evaluation by microCT revealed a high potency of ITPP for tumor growth inhibition, thus allowing long-term survival and even cure of almost all the treated animals. The P50 value of hemoglobin in RBCs underwent a shift of 30 % following ITPP injection. Under these conditions, HIF-1α activity was strongly decreased, VEGF expression was down-regulated, and apoptosis was induced in HCC and surrounding liver cells, as indicated by Caspase-3 expression. ITPP did not affect hematologic parameters during treatment. The observations of in vivo tumor eradication suggest a significant clinical potential for ITPP in cancer therapy. 相似文献
52.
Li W Wang J Jiang HR Xu XL Zhang J Liu ML Zhai LY 《International journal of molecular sciences》2011,12(1):668-681
The present study was designed to investigate the combined effects of cyclooxygenase (COX)-1 and COX-2 selective inhibitors on human ovarian SKOV-3 carcinoma cells xenograft-bearing mice. The animals were treated with 3 mg/kg SC-560 (a COX-1 selective inhibitor) alone, 25 mg/kg celecoxib (a COX-2 selective inhibitor) alone, or SC-560/celecoxib by gavage, twice a day for three weeks. To test the mechanism of inhibition of tumor growth by COX selective inhibitors, the index of proliferating cells in tumor tissues was determined by immunostaining and the index of apoptotic cells by the terminal-deoxynucleotidyl-transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) method. The inhibitory rate on tumor growth in the combination group was 35.54% which is significant statistically compared with that of the control group (P < 0.05). In the combination group, the index of cell proliferation and apoptosis were 12.40% and 51.03% respectively, which are significant statistically compared with those of the control group (22.56%, 19.07%, all P < 0.05). These studies indicate that synergism between two COX inhibitors and inhibitor combination treatment has particular potential for chemoprevention of ovarian cancer growth. 相似文献
53.
精制胸腺活性肽药效学研究 总被引:1,自引:1,他引:1
目的 考察精制胸腺活性肽免疫学活性。方法 建立BALB/c小鼠肝细胞肿瘤(腹水型)模型,经腹腔连续注射肝肿瘤细胞15d,检测各种生命指标,以观察抗肿瘤效果。同时用E-玫瑰花环实验及淋巴细胞转化实验评价其生物学活性。结果 抗肿瘤实验表明,生命各项指标均优于盐水对照组,用药组10d、15d的存活率明显高于对照组;E-玫瑰花环及淋巴细胞转化实验均显示精制胸腺活性肽组明显高于对照组。结论 精制胸腺活性肽具有明显的免疫增强作用。 相似文献
54.
纳米羟基磷灰石的表征及其对肝癌抑制作用的研究 总被引:13,自引:0,他引:13
利用化学方法辅助超声制备出稳定单分散的羟基磷灰石(HAP)纳米粒子体系.应用原子力显微镜(AFM)、粒径电位仪对HAP纳米粒子进行表征;采用形态学观察和MTT比色法研究HAP纳米粒子对细胞系Bel-7402人肝癌细胞的作用;从单细胞荧光元素微区分析、超微结构及细胞周期的改变研究其作用机理.实验结果表明:HAP纳米粒子在体外对Bel-7402人肝癌细胞具有明显的抑制作用,通过进入到癌细胞内,阻滞细胞周期的进展,使细胞在G1期堆积,导致癌细胞胀亡. 相似文献
55.
56.
The cyclooxygenase-2 (COX-2) is a potent enzyme that converts arachidonic acid to prostaglandins (PG), including PGE2, a key mediator of inflammation and angiogenesis. Importantly, COX-2 is activated in response to inflammatory stimuli, where it is also believed to promote the development and progression of head and neck cancers (HNC). COX-2 can mediate its protumorigenic effect through various mechanisms, such as inducing cell proliferation, inhibition of apoptosis, and suppressing the host’s immune response. Furthermore, COX-2 can induce the production of vascular endothelial growth factors, hence, promoting angiogenesis. Indeed, the ability of COX-2 inhibitors to selectively restrict the proliferation of tumor cells and mediating apoptosis provides promising therapeutic targets for cancer patients. Thus, in this comprehensive review, we summarized the reported differential expression patterns of COX-2 in different stages of head and neck carcinogenesis—from potentially premalignant lesions to invasive carcinomas. Furthermore, we examined the available meta-analysis evidence for COX-2 role in the carcinogenesis of HNC. Finally, further understanding of the biological processes of COX-2 and its role in orchestrating cell proliferation, apoptosis, and angiogenesis may give therapeutically beneficial insight to develop the management plan of HNC patients and improve their clinical outcomes. 相似文献
57.
Arianna Giacomini Sara Taranto Sara Rezzola Sara Matarazzo Elisabetta Grillo Mattia Bugatti Alessia Scotuzzi Jessica Guerra Martina Di Trani Marco Presta Roberto Ronca 《International journal of molecular sciences》2020,21(24)
Lung cancer represents an extremely diffused neoplastic disorder with different histological/molecular features. Among the different lung tumors, non-small-cell lung cancer (NSCLC) is the most represented histotype, characterized by various molecular markers, including the expression/overexpression of the fibroblast growth factor receptor-1 (FGFR1). Thus, FGF/FGFR blockade by tyrosine kinase inhibitors (TKi) or FGF-ligand inhibitors may represent a promising therapeutic approach in lung cancers. In this study we demonstrate the potential therapeutic benefit of targeting the FGF/FGFR system in FGF-dependent lung tumor cells using FGF trapping (NSC12) or TKi (erdafitinib) approaches. The results show that inhibition of FGF/FGFR by NSC12 or erdafitinib induces apoptosis in FGF-dependent human squamous cell carcinoma NCI-H1581 and NCI-H520 cells. Induction of oxidative stress is the main mechanism responsible for the therapeutic/pro-apoptotic effect exerted by both NSC12 and erdafitinib, with apoptosis being abolished by antioxidant treatments. Finally, reduction of c-Myc protein levels appears to strictly determine the onset of oxidative stress and the therapeutic response to FGF/FGFR inhibition, indicating c-Myc as a key downstream effector of FGF/FGFR signaling in FGF-dependent lung cancers. 相似文献
58.
The adaptive immune system, including type1 helper T cells (Th1 cells), cytotoxic T lymphocytes (CTLs), and dendritic cells (DCs), plays an important role in the control of hepatitis B virus (HBV). On the other hand, regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) suppress the immune reaction in HBV and hepatocellular carcinoma (HCC). Excessive activation of immune suppressive cells could contribute to the persistent infection of HBV and the progression of HCC. The frequency and/or function of Tregs could affect the natural course in chronic hepatitis B patients and the treatment response. In addition to the suppressive function of MDSCs, MDSCs could affect the induction and function of Tregs. Therefore, we should understand in detail the mechanism by which Tregs and MDSCs are induced to control HBV persistent infection and HBV-related HCC. Immune suppressive cells, including Tregs and MDSCs, contribute to the difficulty in inducing an effective immune response for HBV persistent infection and HBV-related HCC. In this review, we focus on the Tregs and MDSCs that could be potential targets for immune therapy of chronic hepatitis B and HBV-related HCC. 相似文献
59.
Guadalupe Aparicio Gallego Vanessa Medina Villaamil Enrique Grande Isabel Santamarina Ca��nzos Lu��s M. Ant��n Aparicio 《International journal of molecular sciences》2012,13(10):12710-12733
Historically, cell-signaling pathways have been studied as the compilation of isolated elements into a unique cascade that transmits extracellular stimuli to the tumor cell nucleus. Today, growing evidence supports the fact that intracellular drivers of tumor progression do not flow in a single linear pathway, but disseminate into multiple intracellular pathways. An improved understanding of the complexity of cancer depends on the elucidation of the underlying regulatory networks at the cellular and intercellular levels and in their temporal dimension. The high complexity of the intracellular cascades causes the complete inhibition of the growth of one tumor cell to be very unlikely, except in cases in which the so-called “oncogene addiction” is known to be a clear trigger for tumor catastrophe, such as in the case of gastrointestinal stromal tumors or chronic myeloid leukemia. In other words, the separation and isolation of the driver from the passengers is required to improve accuracy in cancer treatment. This review will summarize the signaling pathway crossroads that govern renal cell carcinoma proliferation and the emerging understanding of how these pathways facilitate tumor escape. We outline the available evidence supporting the putative links between different signaling pathways and how they may influence tumor proliferation, differentiation, apoptosis, angiogenesis, metabolism and invasiveness. The conclusion is that tumor cells may generate their own crossroads/crosstalk among signaling pathways, thereby reducing their dependence on stimulation of their physiologic pathways. 相似文献
60.